Gilead Sciences Inc.

NASDAQ: GILD · Real-Time Price · USD
118.42
-0.60 (-0.50%)
At close: Aug 15, 2025, 1:10 PM

Gilead Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
480M 5.67B 4.59B 6.2B
Depreciation & Amortization
2.77B 2.69B 2.1B 2.05B
Stock-Based Compensation
835M 766M 644M 635M
Other Working Capital
-883M -1.27B -1.27B 283M
Other Non-Cash Items
9.47B 2.15B 5.05B 2.13B
Deferred Income Tax
-1.84B -962M -1.55B -116M
Change in Working Capital
-880M -2.3B -1.76B 489M
Operating Cash Flow
10.83B 8.01B 9.07B 11.38B
Capital Expenditures
-523M -585M -728M -579M
Cash Acquisitions
-4.84B -1.15B -1.8B -1.58B
Purchase of Investments
-736M -2.37B -1.94B -3.9B
Sales Maturities Of Investments
2.59B 1.84B 2B 2.91B
Other Investing Acitivies
58M n/a -1M 19M
Investing Cash Flow
-3.45B -2.27B -2.47B -3.13B
Debt Repayment
1.49B -270M -1.5B -4.75B
Common Stock Repurchased
-1.15B -1B -1.4B -546M
Dividend Paid
-3.92B -3.81B -3.71B -3.6B
Other Financial Acitivies
-281M -278M -173M -145M
Financial Cash Flow
-3.43B -5.13B -6.47B -8.88B
Net Cash Flow
3.91B 673M 74M -659M
Free Cash Flow
10.3B 7.42B 8.34B 10.8B